Vanguard Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-1,439,571
| Closed | -$218M | – | 4644 |
|
2022
Q3 | $218M | Buy |
1,439,571
+7,113
| +0.5% | +$1.08M | 0.01% | 1333 |
|
2022
Q2 | $209M | Buy |
1,432,458
+10,732
| +0.8% | +$1.56M | 0.01% | 1399 |
|
2022
Q1 | $169M | Buy |
1,421,726
+52,635
| +4% | +$6.24M | ﹤0.01% | 1649 |
|
2021
Q4 | $189M | Sell |
1,369,091
-8,890
| -0.6% | -$1.23M | ﹤0.01% | 1648 |
|
2021
Q3 | $191M | Buy |
1,377,981
+56,711
| +4% | +$7.88M | ﹤0.01% | 1638 |
|
2021
Q2 | $128M | Buy |
1,321,270
+48,374
| +4% | +$4.7M | ﹤0.01% | 1862 |
|
2021
Q1 | $87M | Buy |
1,272,896
+124,655
| +11% | +$8.52M | ﹤0.01% | 2025 |
|
2020
Q4 | $98.4M | Buy |
1,148,241
+97,739
| +9% | +$8.38M | ﹤0.01% | 1842 |
|
2020
Q3 | $68.3M | Sell |
1,050,502
-454,285
| -30% | -$29.5M | ﹤0.01% | 1861 |
|
2020
Q2 | $110M | Buy |
1,504,787
+110,271
| +8% | +$8.06M | ﹤0.01% | 1624 |
|
2020
Q1 | $47.5M | Buy |
1,394,516
+383,632
| +38% | +$13.1M | ﹤0.01% | 1888 |
|
2019
Q4 | $55M | Buy |
1,010,884
+118,639
| +13% | +$6.46M | ﹤0.01% | 2062 |
|
2019
Q3 | $37.2M | Sell |
892,245
-262,012
| -23% | -$10.9M | ﹤0.01% | 2207 |
|
2019
Q2 | $50.5M | Buy |
1,154,257
+294,098
| +34% | +$12.9M | ﹤0.01% | 2097 |
|
2019
Q1 | $44.3M | Buy |
860,159
+191,923
| +29% | +$9.88M | ﹤0.01% | 2151 |
|
2018
Q4 | $24.7M | Buy |
668,236
+131,725
| +25% | +$4.87M | ﹤0.01% | 2357 |
|
2018
Q3 | $20.1M | Buy |
536,511
+20,785
| +4% | +$780K | ﹤0.01% | 2575 |
|
2018
Q2 | $20.4M | Buy |
515,726
+228,776
| +80% | +$9.04M | ﹤0.01% | 2556 |
|
2018
Q1 | $7.39M | Buy |
286,950
+100,487
| +54% | +$2.59M | ﹤0.01% | 2972 |
|
2017
Q4 | $5.03M | Buy |
186,463
+50,615
| +37% | +$1.37M | ﹤0.01% | 3136 |
|
2017
Q3 | $5.08M | Buy |
135,848
+7,746
| +6% | +$290K | ﹤0.01% | 3113 |
|
2017
Q2 | $3.2M | Buy |
+128,102
| New | +$3.2M | ﹤0.01% | 3243 |
|